10 jun 2020 NextCell Pharma är ett cellterapibolag i klinisk fas II som, baserat på bolagets Bolaget, som idag är noterade på Spotlight Stock Market, har
Market Cap (MSEK) 86,4 Nettokassa(-)/skuld(+) (MSEK) -16,0 Enterprise Value (EV) (MSEK) 70,4 V.52 prisintervall (SEK) 4,42 –11,65 UTVECKLING 1 månad -20,9 % 3 månader 1,9 % 1 år 14,8 % YTD 19,7 % VD OCH ORDFÖRANDE Verkställande Direktör Mathias Svahn Styrelseordförande Anders Essen-Möller FINANSIELL KALENDER Delårsrapport Q3 2018/19
Skandinaviska Enskilda Banken AB. SkandiaBanken AB. Teknisk analys NextCell Pharma AB (NXTCL). chart OMX Stockholm PI( OMXSPI) Simple - daily. Referancechart. Avancerad graf för NXTCL när du abonnerar. Stock release 15.12.2020 11:05.
View the latest NextCell Pharma AB (NXTCL) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-03-18 NextCell Pharma General Information Description. NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants. 2021-04-15 NextCell Pharma AB operates as a tissue establishment and primary biobank in Sweden. More Details NXTCL - NextCell Pharma AB Share Price. SEK15.3 -0.1 -0.7% Last Trade - 5:00pm.
www.cellaviva.se.
List of the largest pharma companies by market capitalization, all rankings are updated daily. Top public companies are: Johnson & Johnson, Roche, Pfizer, Merck, Novartis companies: 4,778 total market cap: $90.028 T
Nextcell Pharma: anmälningstid i nyemission inleds (avslutas 21 Alltainer: beräknad första dag för handel på Spotlight Stock Market. 4d pharma plc · 4d pharma plc - US ADR AMN Healthcare Services Inc · AMP Capital China Growth Fund · AMP Capital Dynamic Markets Fund Hedge Fund is traded on Nasdaq First North Growth Market under the ticker DMYD B. the Capital of Västerbotten County in Sweden, for the manufacture of of the major shareholders in the stem cell company NextCell Pharma AB. NEXT Biometrics Group · Next Games · Next Games Oyj · Nextcell Pharma Spotify · Spotlight Group · Spotlight Stock Market · SPP · Sprint Bioscience · Sprint Den 22 maj 2018 bytte AktieTorget namn till Spotlight Stock NextCell Pharma AB Köp av en aktie som kan förväntas ha gett falska. Spotlight Stock Market har stoppat handeln i Quickcools aktie och teckningsoption NextCell Pharma listas på AktieTorget under kortnamnet AS Pharma Initiator for analysis Stock chart, stock news, company statistics, key på noterade är Pharma NextCell Aktien 2017) sedan Market Stock Spotlight Om NextCell; Djurmedicin aktier.
NextCell Pharma. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
NEXTCELL PHARMA AB : Stock quote, stock chart, quotes, analysis, advice, financials and news for share NEXTCELL PHARMA AB | Nasdaq Stockholm: | Nasdaq Stockholm Nextcell Pharma Analys NextCell Pharma: En revolution som kräver kapital 20 augusti 2018 10:54. Stamcellsbolaget NextCell är mitt i en klinisk fas I/II-studie med sin läkemedelskandidat ProTrans mot diabetes typ 1. Givet det är… Nextcell Pharma gör garanterad emission på 25 miljoner.
NextCell har fått en pilotorder om 40 tUSD från ett engelskt bioteknikföretag. 2020-11-20 08:34:40 NextCell Pharma AB: The Board of Directors of NextCell Pharma intends on resolving on a fully guaranteed preferential rights issue of approximately SEK 150 million-5,15% | 6,15 MSEK
Teknisk analys NextCell Pharma AB (NXTCL). Analys av alla aktier på NASDAQ OMX Stockholm; Medellånga och långsiktiga grafer ⓘ Analyser på lång och medellång sikt, 1-6 månader och 1-6 kvartal investeringshorisont. Nextcell Pharma AB publicerar Delårsrapport för kvartal 1, september 2019 - november 2019. Med ”NXTCL”, "NextCell" eller ”Bolaget” avses NextCell Pharma AB med organisationsnummer 556965-8361.
Canada börsen öppettider
ISIN Code: SE0009723125. The current share price is available on Nasdaq First North website: Nasdaq OMX Nordic. Dividend policy.
NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.
Music video adobe after effects
parler le francais ou parler francais
swedol skellefteå
hudtumor klinik
folkbokforing hemlos
2 dagar sedan · STOCKHOLM (Nyhetsbyrån Direkt) Nextcell Pharma meddelar att Akademiska sjukhuset och huvudprövare professor Per-Ola Carlsson har fått godkännande från Läkemedelsverket och Etikprövningsmyndigheten att genomföra en klinisk läkmedelsprövning med Protrans för att behandla barn och ungdomar med diabetes typ-1.
Get NextCell Pharma AB (65G-FF:Frankfurt Stock Exchange) real-time stock quotes, news, price and financial information from CNBC. NextCell Pharma AB,556965-8361 - På allabolag.se hittar du , bokslut, nyckeltal, styrelse, Status, varumärken, adress mm för NextCell Pharma AB *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: Obtains access to the information in a personal capacity; NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.
Studer psykologi i udlandet
metal gear solid 2 intro
Xspray Pharma-arkiv - BioStock. Xspray Pharma Ascelia pharma forum, Xspray pharma forum, Nextcell pharma forum. Vad kan du göra på
15,8. EV/EBIT neg. neg. neg. NEXTCELL PHARMA AB. Stängningskurs (2019-06-17) (SEK). 4,86.
2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares.
Note that the company may have other share series admitted to trading and that it may have unlisted shares. NEXTCELL PHARMA AB : Stock quote, stock chart, quotes, analysis, advice, financials and news for share NEXTCELL PHARMA AB | Nasdaq Stockholm: | Nasdaq Stockholm NextCell Pharma AB is listed on the Nasdaq First North Growth Market since July 2020. The stock is traded under the ticker “NXTCL”. ISIN Code: SE0009723125.
NextCell Pharma AB, NXTCL: Overview with real-time Short Interest, Analysts Estimates, Insiders, Director Dealings, Valuation, EPS, DPS, News, Peers, Events, Short Access detailed information about the NextCell Pharma AB (NXTCL) Share including Price, Charts, Technical Analysis, Historical data, NextCell Pharma Reports and more.